Abstract
A recent literature review of commentaries and 'state of the art' articles from researchers in psychiatric genetics (PMG) offers a consensus about progress in the science of genetics, disappointments in the discovery of new and effective treatments, and a general optimism about the future of the field. I argue that optimism for the field of psychiatric molecular genetics (PMG) is overwrought, and consider progress in the field in reference to a sample estimate of US National Institute of Mental Health funding for this paradigm for the years 2008 and 2009. I conclude that the amounts of financial investment in PMG is questionable from an ethical perspective, given other research and clinical needs in the USA.
Original language | English (US) |
---|---|
Pages (from-to) | 27-34 |
Number of pages | 8 |
Journal | Journal of Bioethical Inquiry |
Volume | 8 |
Issue number | 1 |
DOIs | |
State | Published - Mar 2011 |
Keywords
- Ethics
- Mental disorders
- Molecular genetics
- Psychiatry
ASJC Scopus subject areas
- Health(social science)
- Health Policy